Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Prof. Alistair Nichol

University College Dublin

Alistair is the Chair and Professor of Critical Care Medicine in University College Dublin (UCD), the Chair of the Irish Critical Care-Clinical Trials Group (ICC-CTG), Director of the HRB Irish Critical Care- Clinical Trials Network (HRB ICC-CTN), Dept Director of the Australian and New Zealand Intensive Care-Research Centre (ANZIC- RC), Monash University, Melbourne and an Honorary Research Fellow, School of Tropical Medicine, University of Oxford.

Alistair is a senior clinical intensivist, laboratory scientist and clinical trialist. Alistair and his collaborators have successfully completed a number of important trials and epidemiological studies (enrolled over 10,000 patients in the last 10 years), including during the H1N1 2009 pandemic (900 patients) published in the NEJM, an RCT of Erythropoietin in traumatic brain injury (606 patients) published in the Lancet (first author-joint). Furthermore he is a Work Package leader of a European Union FP-7 project, which is charged with examining the challenges of conducting interventional studies in critically ill patients throughout Europe.This project is examining embedding of research into clinical practise, examining the acceptability and understanding of consent process used in the critically ill. To date Professor Nichol’s collaborations have been awarded over €35,000,000 in research funding. This has included an award for TRANSFUSE (HRB Definative Intervention award) published in the NEJM this year (5000 patients, first author-joint) and a Clinical Trial Network Award (Improving outcomes in the critically ill) from the Health Research Board of Ireland.